Related references
Note: Only part of the references are listed.The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
Alexandra Wojtalla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Angiotensin signalling in pulmonary fibrosis
Bruce D. Uhal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Hepatocyte-specific Deletion of Janus Kinase 2 (JAK2) Protects against Diet-induced Steatohepatitis and Glucose Intolerance
Sally Yu Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
Sabine Klein et al.
LABORATORY INVESTIGATION (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
JAK2 the future: therapeutic strategies for JAK-dependent malignancies
Lindsay M. LaFave et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Canonical Notch Pathway Protects Hepatocytes from Ischemia/Reperfusion Injury in Mice by Repressing Reactive Oxygen Species Production Through JAK2/STAT3 Signaling
Heng-Chao Yu et al.
HEPATOLOGY (2011)
Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2
Brandon C. Sos et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2
Martin Coenen et al.
LABORATORY INVESTIGATION (2011)
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
Fang-Ming Gu et al.
MOLECULAR CANCER (2011)
Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
Jonel Trebicka et al.
LIVER INTERNATIONAL (2011)
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status
Terry K. W. Ma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2010)
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
Volker Rudolph et al.
NATURE MEDICINE (2010)
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure
Christophe Guilluy et al.
NATURE MEDICINE (2010)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation
Ashley M. Lakner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
Sebastian Huss et al.
FIBROGENESIS & TISSUE REPAIR (2010)
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
Montserrat Moreno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver Fibrosis
Fiona Oakley et al.
GASTROENTEROLOGY (2009)
Role of beta(3)-Adrenoceptors for Intrahepatic Resistance and Portal Hypertension in Liver Cirrhosis
Jonel Trebicka et al.
HEPATOLOGY (2009)
A novel model of CCl4-induced cirrhosis with ascites in the mouse
Marco Domenicali et al.
JOURNAL OF HEPATOLOGY (2009)
Novel aspects of the renin-angiotensin-aldosterone-system
Gunter Wolf
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Platelet-derived growth factor signaling through ephrin-B2 regulates hepatic vascular structure and function
David Semela et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Mechanisms of extrahepatic vasodilation in portal hypertension
M. Hennenberg et al.
GUT (2008)
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase Mediates Fibrotic and Inflammatory Effects of Leptin on Hepatic Stellate Cells
Samuele De Minicis et al.
HEPATOLOGY (2008)
Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
Jonel Trebicka et al.
HEPATOLOGY (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited
W Laleman et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets
A. M. Gressner et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study
Silvia Sookoian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
L Yang et al.
JOURNAL OF HEPATOLOGY (2005)
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis
J Heller et al.
LIVER INTERNATIONAL (2005)
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats
R Bataller et al.
HEPATOLOGY (2005)
Natural history of compensated viral cirrhosis:: a prospective study on the incidence and hierarchy of major complications
L Benvegnù et al.
GUT (2004)
Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats
J Heller et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension
V Croquet et al.
JOURNAL OF HEPATOLOGY (2002)
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
R Bataller et al.
GASTROENTEROLOGY (2000)
Complications of cirrhosis. I. Portal hypertension
J Bosch et al.
JOURNAL OF HEPATOLOGY (2000)